The second annual HCM Society Scientific Sessions will focus on advanced heart failure in non-obstructive HCM, biomarkers of disease progression, bench to bedside effects of exercise, novel therapies and our deepening understanding of the use of cardiac myosin inhibitors.
Officially endorsed by the Heart Failure Society of America.
The opinions presented in this educational activity do not necessarily reflect the opinions or recommendations of the HFSA.
In support of improving patient care, this activity has been planned and implemented by HCMS and the Heart Failure Society of America. The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Heart Failure Society of America designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Learners should claim only the credit commensurate with the extent of their participation in the activity.